Company / Free Cash Flow per Share
Upstream Bio, Inc. Free Cash Flow per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$2.49
FY2025
5-year range
-$12.89 / -$2.49
FY2023-FY2025
Trend
+80.4%
vs FY2024
Sector context
#143 of 192
Health Care
What the data says
At $-2.49, Upstream Bio, Inc.'s free cash flow per share ranks #143 of 192 in the Health Care sector. Improved from $-12.89 to $-2.49 over the past 2 years.
Based on SEC 10-K filings.
-2.49 in FY2025.
Improved from $-12.89 to $-2.49 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#143 of 192 in Health CareTop 74% of 192This company -$2.49 Sector average -$19.84
▼
+87.5% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 80.4% year-over-year.
- Ranks #143 out of 192 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 8.68 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.49 | +80.4% |
| FY2024 | -$12.72 | +1.3% |
| FY2023 | -$12.89 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026